Breaking the Hypoxic Code: Metformin as a Master Switch in Cancer Cell Metabolic Adaptation
The Yale Journal of Biology and Medicine · 04.11.2026 · 99 (3) · 617-652
DOI: 10.59249/gyce4636 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Yale Journal of Biology and Medicine, online erschienen am 04.11.2026. Verfasst von Özge Bayrak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dokuz Eylul University, Institute of Health Sciences, Department of Translational Oncology, Izmir, Turkey. Hauptthemen laut MEDLINE: Metformin, Neoplasms, Adaptation, Physiological. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dokuz Eylul University, Institute of Health Sciences, Department of Translational Oncology, Izmir, Turkey.
- Dokuz Eylul University, Institute of Oncology, Department of Translational Oncology, Izmir, Turkey.
- Dokuz Eylul University, Faculty of Medicine, Department of Cardiovascular Surgery, Izmir, Turkey.
ORCID-Profile: Özge Bayrak, Meltem Alper, Yasemin Başbınar, Serdar Bayrak
Zitieren
APA
Bayrak, Ö., Alper, M., Başbınar, Y., & Bayrak, S. (2026). Breaking the Hypoxic Code: Metformin as a Master Switch in Cancer Cell Metabolic Adaptation. The Yale Journal of Biology and Medicine, 99(3), 617-652. https://doi.org/10.59249/gyce4636
Vancouver
Bayrak Ö, Alper M, Başbınar Y, Bayrak S. Breaking the Hypoxic Code: Metformin as a Master Switch in Cancer Cell Metabolic Adaptation. The Yale Journal of Biology and Medicine. 2026;99(3):617-652. doi:10.59249/gyce4636
BibTeX
@article{Bayrak2026,
author = {Bayrak, Özge and Alper, Meltem and Başbınar, Yasemin and Bayrak, Serdar},
title = {Breaking the Hypoxic Code: Metformin as a Master Switch in Cancer Cell Metabolic Adaptation},
journal = {The Yale Journal of Biology and Medicine},
year = {2026},
volume = {99},
number = {3},
pages = {617--652},
doi = {10.59249/gyce4636}
}
EUVIMED